Perkins Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | $1.54M | Sell |
47,990
-26,783
| -36% | -$859K | 0.02% | 199 |
|
2016
Q4 | $2.71M | Buy |
74,773
+18,407
| +33% | +$667K | 0.03% | 190 |
|
2016
Q3 | $2.59M | Buy |
56,366
+2,045
| +4% | +$94.1K | 0.04% | 185 |
|
2016
Q2 | $2.73M | Buy |
54,321
+1,049
| +2% | +$52.7K | 0.04% | 188 |
|
2016
Q1 | $2.85M | Buy |
53,272
+3,066
| +6% | +$164K | 0.04% | 198 |
|
2015
Q4 | $3.3M | Sell |
50,206
-30,880
| -38% | -$2.03M | 0.05% | 186 |
|
2015
Q3 | $4.33M | Sell |
81,086
-34,713
| -30% | -$1.85M | 0.06% | 175 |
|
2015
Q2 | $6.84M | Sell |
115,799
-634,707
| -85% | -$37.5M | 0.08% | 184 |
|
2015
Q1 | $46.8M | Sell |
750,506
-618,483
| -45% | -$38.5M | 0.47% | 77 |
|
2014
Q4 | $78.7M | Sell |
1,368,989
-166,112
| -11% | -$9.55M | 0.74% | 46 |
|
2014
Q3 | $82.5M | Sell |
1,535,101
-184,531
| -11% | -$9.92M | 0.76% | 47 |
|
2014
Q2 | $90.1M | Sell |
1,719,632
-205,198
| -11% | -$10.8M | 0.73% | 50 |
|
2014
Q1 | $102M | Sell |
1,924,830
-1,203,766
| -38% | -$63.6M | 0.78% | 48 |
|
2013
Q4 | $125M | Sell |
3,128,596
-415,164
| -12% | -$16.6M | 0.87% | 41 |
|
2013
Q3 | $134M | Sell |
3,543,760
-258,069
| -7% | -$9.75M | 0.92% | 35 |
|
2013
Q2 | $149M | Buy |
+3,801,829
| New | +$149M | 1.01% | 20 |
|